Nov 9 (Reuters) - ImpediMed Ltd:
* ASTRAZENECA FURTHER EXTENDS CLINICAL TRIAL CONTRACT
* ASTRAZENECA FURTHER EXTENDS CLINICAL TRIAL CONTRACT
* EXTENSION OF TRIAL WILL GENERATE OVER A$1.0 MILLION OF ADDITIONAL REVENUE FOR REMAINDER OF 2023 FINANCIAL YEAR
* IN TOTAL, OVER A$6.7 MILLION IN CONTRACT VALUE HAS BEEN SIGNED UNDER VARIOUS ASTRAZENECA TRIAL AGREEMENTS Source text for Eikon: Further company coverage: